Home > Balance Sheet > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Total Non-Current Liabilities

    Back to Balance Sheet
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
Total Non-Current Liabilities ₹12 Cr₹10.00 Cr₹8.66 Cr₹7.76 Cr₹7.73 Cr

What is the latest Total Non-Current Liabilities ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Total Non-Current Liabilities ratio of SYNCOM FORMULATIONS (INDIA) is ₹12 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Liabilities
Mar2025₹12 Cr
Mar2024₹10.00 Cr
Mar2023₹8.66 Cr
Mar2022₹7.76 Cr
Mar2017₹7.73 Cr

How is Total Non-Current Liabilities of SYNCOM FORMULATIONS (INDIA) Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹12 Cr
18.16
Mar2024 ₹10.00 Cr
15.49
Mar2023 ₹8.66 Cr
11.53
Mar2022 ₹7.76 Cr
0.36
Mar2017 ₹7.73 Cr -

Compare Total Non-Current Liabilities of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,238.9 Cr -4% -5.8% -28.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹466,179.0 Cr -0.4% 4.3% 13.6% Stock Analytics
DIVIS LABORATORIES ₹196,095.0 Cr 0.9% 8.9% 8% Stock Analytics
TORRENT PHARMACEUTICALS ₹191,530.0 Cr 0.7% 13% 46.5% Stock Analytics
CIPLA ₹114,318.0 Cr -1% -0% -3.9% Stock Analytics
DR REDDYS LABORATORIES ₹98,742.1 Cr -3.3% -8.4% -4.3% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-4%

-5.8%

-28.3%

SENSEX

-0.6%

-0.1%

-6.7%


You may also like the below Video Courses